A comparative study of different doses of propofol combined with its equivalent dose of alfentanil for day abortion surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046111

Enrollment

Unknown

Registered

2021-05-04

Start date

2021-05-16

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

day abortion surgery

Interventions

Part I:Alfentanil (2.5-13.0)ug/kg + propofol 2.5mg/kg

GroupA in the Part II:Alfentanil + propofol 2.0mg/kg

Group B in the Part II:Alfentanil + propofol 2.0mg/kg

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Consent to participate in this study. 2.Aged 18 to 40 years; 3.BMI 18-28; 4.ASAI grade-II female patients; 5.Within 60 days of pregnancy; 6.Planned to undergo painless artificial abortion surgery.

Exclusion criteria

Exclusion criteria: 1.Severe cardiovascular and cerebrovascular diseases; 2.Hepatitis; 3.Kidney disease, severe anemia and malnutrition; 4.History of endocrine disease; 5.History of chronic pain; 6.History of mental illness or psychotropic drug dependence; 7.Patients who are allergic to alfentaniland propofol.

Design outcomes

Primary

Measure	Time frame
body movement response;Intraoperative RASS score;	—

Secondary

Measure	Time frame
Post-operative pain score;	—

Countries

China

Contacts

Public ContactJin Linda

Yuhang District Women and Children Care Hospital

littledandan_927@sina.com+86 15967106092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026